Company Filing History:
1 out of 495 
1 out of 258 Years Active: 2022
Title: Chitra Venugopal: Innovator in Cancer Research
Introduction
Chitra Venugopal is a prominent inventor based in Burlington, California. She has made significant contributions to the field of cancer research through her innovative work on CD133-binding agents. Her research focuses on the detection and quantification of CD133-expressing cells, which play a crucial role in cancer progression.
Latest Patents
Chitra holds one patent titled "CD133-binding agents and uses thereof." This patent discloses novel CD133-binding agents that are instrumental in detecting CD133-expressing cells. The applications of these agents extend to targeting CD133-expressing cells, decreasing levels of CD133 in these cells, and providing potential treatments for cancer.
Career Highlights
Throughout her career, Chitra has worked with esteemed institutions such as the University of Toronto and McMaster University. Her research has garnered attention for its potential impact on cancer therapies and diagnostics.
Collaborations
Chitra has collaborated with notable colleagues, including Jason Moffat and Jarrett Adams, who have contributed to her research endeavors.
Conclusion
Chitra Venugopal's innovative work in developing CD133-binding agents showcases her commitment to advancing cancer research. Her contributions have the potential to significantly influence cancer detection and treatment strategies.